Cognitive Function in Older Women With Stage I, Stage II, or Stage III Breast Cancer Receiving Hormone Therapy

CompletedOBSERVATIONAL
Enrollment

72

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions
Breast Cancer
Interventions
DRUG

anastrozole

As determined by the subject's physician

DRUG

letrozole

As determined by the subject's physician

OTHER

questionnaire administration

For cancer patients prior to starting medication and 6 months after starting medication. For healthy controls, one time administration.

PROCEDURE

cognitive assessment

For cancer patients prior to starting medication and 6 months after starting medication. For healthy controls, one time administration.

PROCEDURE

psychosocial assessment and care

For cancer patients prior to starting medication and 6 months after starting medication. For healthy controls, one time administration.

Trial Locations (1)

91010-3000

City of Hope Comprehensive Cancer Center, Duarte

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

City of Hope Medical Center

OTHER

NCT00681928 - Cognitive Function in Older Women With Stage I, Stage II, or Stage III Breast Cancer Receiving Hormone Therapy | Biotech Hunter | Biotech Hunter